EP300 has also been identified as a co-activator of HIF1A, which plays a role in the stimulation of hypoxia-induced genes such as VEGF. Mutations in EP300 are a rare cause of Rubinstein-Taybi syndrome (RSTS) (OMIM#180849). This evidence concerns the gene HIF1A and Rubinstein-Taybi syndrome.